IRIS Institutional Research Information System - OPENBS Open Archive UniBS

BOSSI, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.436
AS - Asia 9.672
EU - Europa 5.226
SA - Sud America 2.120
AF - Africa 228
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 4
Totale 33.709
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.120
SG - Singapore 3.232
CN - Cina 2.501
HK - Hong Kong 1.893
BR - Brasile 1.800
UA - Ucraina 887
IT - Italia 732
VN - Vietnam 707
DE - Germania 619
FR - Francia 392
IE - Irlanda 390
PL - Polonia 389
TR - Turchia 389
RU - Federazione Russa 384
GB - Regno Unito 362
FI - Finlandia 328
EE - Estonia 295
IN - India 206
BD - Bangladesh 175
CA - Canada 142
AR - Argentina 138
ID - Indonesia 124
SE - Svezia 107
MX - Messico 93
IQ - Iraq 84
AT - Austria 83
ZA - Sudafrica 81
NL - Olanda 59
EC - Ecuador 54
PK - Pakistan 52
JP - Giappone 50
SA - Arabia Saudita 45
CZ - Repubblica Ceca 44
ES - Italia 42
EG - Egitto 39
CO - Colombia 31
MA - Marocco 29
VE - Venezuela 28
PY - Paraguay 26
UZ - Uzbekistan 26
CH - Svizzera 24
NP - Nepal 22
JO - Giordania 21
AU - Australia 20
MY - Malesia 18
JM - Giamaica 17
KE - Kenya 17
PE - Perù 17
AZ - Azerbaigian 15
IL - Israele 14
BE - Belgio 13
CL - Cile 13
CR - Costa Rica 12
TN - Tunisia 12
AE - Emirati Arabi Uniti 11
KZ - Kazakistan 11
DO - Repubblica Dominicana 10
IR - Iran 10
LT - Lituania 10
DZ - Algeria 9
ET - Etiopia 8
HN - Honduras 8
NI - Nicaragua 8
OM - Oman 8
PH - Filippine 8
AL - Albania 7
MD - Moldavia 7
PA - Panama 7
SN - Senegal 7
UY - Uruguay 7
BH - Bahrain 6
HR - Croazia 6
LB - Libano 6
LY - Libia 6
MK - Macedonia 6
TH - Thailandia 6
AO - Angola 5
BB - Barbados 5
DK - Danimarca 5
KG - Kirghizistan 5
PT - Portogallo 5
TT - Trinidad e Tobago 5
EU - Europa 4
GR - Grecia 4
GT - Guatemala 4
KR - Corea 4
LK - Sri Lanka 4
MU - Mauritius 4
BG - Bulgaria 3
BO - Bolivia 3
BY - Bielorussia 3
GE - Georgia 3
KW - Kuwait 3
MT - Malta 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
AM - Armenia 2
CI - Costa d'Avorio 2
GH - Ghana 2
GY - Guiana 2
Totale 33.671
Salva come PNG Salva come JPEG
Città #
Fairfield 2.232
Hong Kong 1.884
Ashburn 1.635
Singapore 1.553
Seattle 920
Woodbridge 898
Jacksonville 850
Houston 794
The Dalles 755
Cambridge 695
Wilmington 674
Princeton 636
San Jose 578
Beijing 562
Dallas 472
New York 457
Chandler 416
Warsaw 381
Dublin 347
Istanbul 323
Lauterbourg 303
Tallinn 295
Ann Arbor 282
Los Angeles 271
Helsinki 257
Council Bluffs 241
Ho Chi Minh City 205
Des Moines 171
Nanjing 163
San Diego 153
Redondo Beach 151
São Paulo 138
Hanoi 133
Buffalo 124
Brescia 123
Moscow 104
Munich 98
London 96
Milan 94
Chicago 86
Jakarta 85
Shanghai 82
Changsha 79
Nuremberg 76
Shenyang 75
Santa Clara 74
San Francisco 73
Tianjin 61
Brooklyn 58
Dong Ket 58
Jinan 58
Nanchang 57
Rome 56
Orem 54
Hebei 52
Jiaxing 52
Frankfurt am Main 50
Johannesburg 47
Menlo Park 43
Tokyo 43
Guangzhou 42
Pune 41
Hangzhou 40
Rio de Janeiro 40
Belo Horizonte 38
Toronto 38
Montreal 37
Turku 37
Chennai 34
Vienna 34
Brno 33
Haiphong 33
Brasília 32
Curitiba 31
Denver 30
Salt Lake City 30
Atlanta 29
Baghdad 29
Fortaleza 28
Zhengzhou 28
Campinas 27
Da Nang 27
Lappeenranta 27
Ningbo 27
Phoenix 27
Kilburn 26
Boardman 25
Manchester 25
Cairo 24
Salvador 24
Boston 23
Poplar 23
Mexico City 22
Norwalk 22
Taizhou 21
Amman 20
Schiffdorf 20
Stockholm 20
Tashkent 20
Erbil 19
Totale 22.936
Salva come PNG Salva come JPEG
Nome #
A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck 815
Systematic review of photobiomodulation for the managementof oral mucositis in cancer patients and clinical practice guidelines 373
Systematic review of natural and miscellaneous agents for the management of oral mucositis in cancer patients and clinical practice guidelines-part 1: vitamins, minerals, and nutritional supplements. 332
The 8th TNM classification for oral squamous cell carcinoma: What is gained, what is lost, and what is missing 237
Prognostic Nomograms in Oral Squamous Cell Carcinoma: The Negative Impact of Low Neutrophil to Lymphocyte Ratio 226
Clinical and histological prognostic factors of recurrent and/or metastatic salivary gland adenoid cystic carcinoma 223
Pretreatment DWI with Histogram Analysis of the ADC in Predicting the Outcome of Advanced Oropharyngeal Cancer with Known Human Papillomavirus Status Treated with Chemoradiation 212
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement 209
Gene expression profiling to improve prognostic characterization of olfactory neuroblastoma and to define new targetable pathways 193
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement 178
Immunotherapy for the prevention of high-risk oral disorders malignant transformation: the IMPEDE trial 178
Gene Expression Clustering and Selected Head and Neck Cancer Gene Signatures Highlight Risk Probability Differences in Oral Premalignant Lesions 177
Prognosis and management of recurrent and/or metastatic head and neck adenoid cystic carcinoma 174
Malignant tumors of the maxillary sinus: Prognostic impact of neurovascular invasion in a series of 138 patients 169
Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma 169
Acute skin toxicity management in head and neck cancer patients treated with radiotherapy and chemotherapy or EGFR inhibitors: Literature review and consensus 165
Tumor biomarkers for the prediction of distant metastasis in head and neck squamous cell carcinoma 165
A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact 161
Activity and safety of afatinib in a window preoperative EORTC study in patients with squamous cell carcinoma of the head and neck (SCCHN) 158
Systemic therapy in metastatic salivary gland carcinomas: A pathology-driven paradigm? 157
Systematic review of natural and miscellaneous agents, for the management of oral mucositis in cancer patients and clinical practice guidelines - part 2: honey, herbal compounds, saliva stimulants, probiotics, and miscellaneous agents 156
The Spread of SARS-CoV-2 Infection Among the Medical Oncology Staff of ASST Spedali Civili of Brescia: Efficacy of Preventive Measures 153
Baseline prognostic factors affecting survival in recurrent and/or metastatic salivary gland adenoid cystic carcinoma 152
Dysphagia in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus 151
Absence of ALK and MET alterations in head and neck sarcomatoid carcinoma 150
Activity of abiraterone in rechallenging two AR-expressing salivary gland adenocarcinomas, resistant to androgen-deprivation therapy 146
Gene expression profiling of olfactory neuroblastoma helps identify prognostic pathways and define potentially therapeutic targets 142
Not all hematopoietic growth factors are created equal: Should we gain information for their use with immunotherapy? 139
A European survey on the practice of nutritional interventions in head–neck cancer patients undergoing curative treatment with radio(chemo)therapy 137
Risk of oral and gastrointestinal mucosal injury among patients receiving selected targeted agents: a meta-analysis 136
Sepsis in head and neck cancer patients treated with chemotherapy and radiation: Literature review and consensus 135
Comprehensive gene expression meta-analysis of head and neck squamous cell carcinoma microarray data defines a robust survival predictor 134
Treatment relevant target immunophenotyping of 139 salivary gland carcinomas (SGCs) 133
Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients 133
A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high-dose cisplatin 133
Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 Pandemic 132
Clinical and Histological Prognostic Factors of Recurrence and Malignant Transformation in a Large Series of Oral Potentially Malignant Disorders 131
Precision medicine in rare tumors and the need for multicenter trials and international collaboratives: Sinonasal cancer as paradigm 131
Cumulative cisplatin dose in concurrent chemoradiotherapy for head and neck cancer: A systematic review 130
Functional profiles of curatively treated adenoid cystic carcinoma unveil prognostic features and potentially targetable pathways 129
Clinical activity of androgen deprivation therapy in patients with metastatic/relapsed androgen receptor-positive salivary gland cancers 129
Assessing Preferences in Patients with Head and Neck Squamous Cell Carcinoma: Phase I and II of Questionnaire Development 129
Outcome of patients with intrathyroidal thymic carcinoma: a pooled analysis 129
Folate in head and neck squamous cell cancer chemoprevention: Purposely left out? 128
A ct-based radiomic signature can be prognostic for 10-months overall survival in metastatic tumors treated with nivolumab: An exploratory study 128
Uso di miRNA come biomarcatori per la diagnosi e prognosi del carcinoma orale a cellule squamose 127
T-cell therapy for EBV-associated nasopharyngeal carcinoma: preparative lymphodepleting chemotherapy does not improve clinical results 126
Investigational drugs for head and neck cancer 125
The role of systemic therapy in the management of sinonasal cancer: A critical review 125
Financial toxicity questionnaire (FIT): development and validation of the italian version (FITALY) in head and neck cancer patients undergoing multimodal curative treatment 124
Safety and feasibility of every-other-week maintenance cetuximab after first-line chemotherapy in patients with recurrent or metastatic head and neck squamous cell cancer 124
Multikinase inhibitors in thyroid cancer 121
A NATURAL HISTORY OF A SERIES OF RADIOACTIVE IODINE (131I-RAI)-RESISTANT ADVANCED DIFFERENTIATED THYROID CANCER (DTC) 120
Mining of self-organizing map gene-expression portraits reveals prognostic stratification of HPV-positive head and neck squamous cell carcinoma 120
Molecular and cytogenetic subgroups of oropharyngeal squamous cell carcinoma 120
Health care-associated infections in patients with head and neck cancer treated with chemotherapy and/or radiotherapy 119
Hope in cancer patients: the relational domain as a crucial factor 119
Regional disease in head and neck cutaneous squamous cell carcinoma: the role of primary tumor characteristics and number of nodal metastases 118
Advanced lung cancer inflammation index and its prognostic value in HPV-negative head and neck squamous cell carcinoma: a multicentre study 118
CISPLATIN DOSE INTENSITY CORRELATES WITH OUTCOME IN PATIENTS WITH LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA RECEIVING CONCURRENT CISPLATIN BASED CHEMORADIATION: A MULTI-INSTITUTIONAL EXPERIENCE 117
Treatment Stratification in First-Line Recurrent or Metastatic Head and Neck Cancer, on Behalf of the EORTC Young Investigator Head and Neck Cancer Group 117
Prolonged response using gefitinib followed by sirolimus for advanced cutaneous squamous cell carcinoma 116
Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation study 116
Role of EGFR family receptors in proliferation of squamous carcinoma cells induced by wound healing fluids of head and neck cancer patients 116
Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study 116
Receptor tyrosine kinase profiles and human papillomavirus status in oropharyngeal squamous cell carcinoma 116
Treatment-related outcome of oropharyngeal cancer patients differentiated by HPV dictated risk profile: a tertiary cancer centre series analysis 116
Smoothened (SMO) receptor mutations dictate resistance to vismodegib in basal cell carcinoma 116
Feasibility and activity of docetaxel, cisplatinum and 5-fluorouracil induction chemotherapy followed by concurrent chemo-radiotherapy (including IMRT) in locally advanced undifferentiated nasopharyngeal cancer (LANPC) 116
New Challenges in Evaluating Outcomes after Immunotherapy in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma 115
Treatment and outcome of metastatic parathyroid carcinoma: A systematic review and pooled analysis of published cases 115
Circulating pretreatment Epstein Barr Virus DNA quantification as a prognostic factor in nasopharyngeal cancer patients in a non endemic area 115
Italian version of the MD Anderson Symptom Inventory-Head and Neck Module: linguistic validation 114
Critical analysis of locoregional failures following intensity-modulated radiotherapy for nasopharyngeal carcinoma 113
TP53 Mutations and Pathologic Complete Response to Neoadjuvant Cisplatin and Fluorouracil Chemotherapy in Resected Oral Cavity Squamous Cell Carcinoma 113
A functional gene expression analysis in epithelial sinonasal cancer: Biology and clinical relevance behind three histological subtypes 113
Clinical outcomes, Kadish-INSICA staging and therapeutic targeting of somatostatin receptor 2 in olfactory neuroblastoma 113
New insights in chemotherapy 112
Evolutionary Action Score of TP53 Coding Variants Is Predictive of Platinum Response in Head and Neck Cancer Patients 112
Functional Genomics Uncover the Biology behind the Responsiveness of Head and Neck Squamous Cell Cancer Patients to Cetuximab 112
Preoperative chemotherapy in advanced resectable OCSCC: long-term results of a randomized phase III trial 112
International Multicenter Study of Clinical Outcomes of Sinonasal Melanoma Shows Survival Benefit for Patients Treated with Immune Checkpoint Inhibitors and Potential Improvements to the Current TNM Staging System 111
Radiotherapy for unresectable sinonasal cancers: Dosimetric comparison of intensity modulated radiation therapy with coplanar and non-coplanar volumetric modulated arc therapy 111
Nausea and vomiting during the first 3 intercycle periods in chemo-naive cancer patients receiving moderately/highly emetogenic therapy 111
Pain management in head and neck cancer patients undergoing chemo-radiotherapy: Clinical practical recommendations 110
The Benefit of a Multidisciplinary Approach to the Patient Treated with (Chemo) Radiation for Head and Neck Cancer 110
Emerging tyrosine kinase inhibitors for head and neck cancer 110
Surveillance of Patients with Head and Neck Cancer with an Intensive Clinical and Radiologic Follow-up 110
Cohort analysis of safety and efficacy of vismodegib in Italian patients from the Phase II, multicenter STEVIE study 110
The Case Volume Issue in Head and Neck Oncology 110
Prognostic and predictive value of EGFR in head and neck squamous cell carcinoma 110
Cytotoxic effects of targeted agent alone or with chemotherapy in the treatment of adenoid cystic carcinoma: a preclinical study 109
Head and neck cancer subtypes with biological and clinical relevance: Meta-analysis of gene-expression data 109
NICSO: Network Italiano Cure di Supporto in Oncologia - Italian Network for Supportive Care in Oncology 109
Mucositis in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus statements 109
A complete remission with androgen-deprivation therapy in a recurrent androgen recptor-expressing adenocarcinoma of the parotid gland [1] 109
Differential impact of cisplatin dose intensity on human papillomavirus (HPV)-related (+) and HPV-unrelated (-) locoregionally advanced head and neck squamous cell carcinoma (LAHNSCC) 108
Salivary Cytokine Levels and Oral Mucositis in Head and Neck Cancer Patients Treated With Chemotherapy and Radiation Therapy 108
TP53 mutations in head and neck cancer 108
Circulating pretreatment Epstein Barr Virus DNA quantification as a prognostic factor in nasopharyngeal cancer patients in a non endemic area 108
Totale 14.404
Salva come PNG Salva come JPEG
Categoria #
all - tutte 203.578
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 203.578
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021364 0 0 0 0 0 0 0 0 0 0 0 364
2021/20222.337 116 253 56 283 109 212 76 202 120 195 201 514
2022/20231.518 359 89 46 113 92 464 8 96 144 26 37 44
2023/20242.385 64 36 117 107 122 577 90 137 665 39 33 398
2024/20255.799 32 21 69 1.028 543 536 336 134 730 555 1.132 683
2025/202612.201 1.063 2.379 1.309 1.712 773 632 1.471 462 715 1.042 495 148
Totale 34.123